Molecular genetics of bipolar disorder and depression

Молекулярная генетика биполярного расстройства и депрессии
Tadafumi Kato
2007-01-12

bipolar disordercandidate genesdepressionmolecular geneticspharmacogenetics
In this review, all papers relevant to the molecular genetics of bipolar disorder published from 2004 to the present (mid 2006) are reviewed, and major results on depression are summarized. Several candidate genes for schizophrenia may also be associated with bipolar disorder: G72, DISC1, NRG1, RGS4, NCAM1, DAO, GRM3, GRM4, GRIN2B, MLC1, SYNGR1, and SLC12A6. Of these, association with G72 may be most robust. However, G72 haplotypes and polymorphisms associated with bipolar disorder are not consistent with each other. The positional candidate approach showed an association between bipolar disorder and TRPM2 (21q22.3), GPR50 (Xq28), Citron (12q24), CHMP1.5 (18p11.2), GCHI (14q22-24), MLC1 (22q13), GABRA5 (15q11-q13), BCR (22q11), CUX2, FLJ32356 (12q23-q24), and NAPG (18p11). Studies that focused on mood disorder comorbid with somatic symptoms, suggested roles for the mitochondrial DNA (mtDNA) 3644 mutation and the POLG mutation. From gene expression analysis, PDLIM5, somatostatin, and the mtDNA 3243 mutation were found to be related to bipolar disorder. Whereas most previous positive findings were not supported by subsequent studies, DRD1 and IMPA2 have been implicated in follow-up studies. Several candidate genes in the circadian rhythm pathway, BmaL1, TIMELESS, and PERIOD3, are reported to be associated with bipolar disorder. Linkage studies show many new linkage loci. In depression, the previously reported positive finding of a gene-environmental interaction between HTTLPR (insertion/deletion polymorphism in the promoter of a serotonin transporter) and stress was not replicated. Although the role of the TPH2 mutation in depression had drawn attention previously, this has not been replicated either. Pharmacogenetic studies show a relationship between antidepressant response and HTR2A or FKBP5. New technologies for comprehensive genomic analysis have already been applied. HTTLPR and BDNF promoter polymorphisms are now found to be more complex than previously thought, and previous papers on these polymorphisms should be treated with caution. Finally, this report addresses some possible causes for the lack of replication in this field.
1
Circadian-rhythm genes BmaL1, TIMELESS, and PERIOD3 were reported as associated with bipolar disorder, while depression pharmacogenetic studies linked antidepressant response to HTR2A and FKBP5.
2
Mitochondrial and somatic-symptom-focused studies implicated mtDNA mutations at positions 3644 and 3243, as well as POLG, in mood-disorder biology.
3
Most previously reported bipolar-disorder genetic associations failed replication, although DRD1 and IMPA2 received support in follow-up studies.
4
Positional-candidate studies identified bipolar-disorder associations across multiple loci, including TRPM2, GPR50, Citron, CHMP1.5, GCHI, MLC1, GABRA5, BCR, CUX2, FLJ32356, and NAPG.
5
Previously reported associations of depression with HTTLPR–stress interaction and TPH2 mutations were not replicated; HTTLPR and BDNF promoter variation appear more complex than initially thought.
6
Several schizophrenia candidate genes are also associated with bipolar disorder, with G72 showing the most robust but inconsistent association across haplotypes and polymorphisms.

Molecular genetic factors underlying bipolar disorder and depression

Genetic associations, linkage loci, gene–environment interactions, gene expression patterns, and pharmacogenetic effects related to disease susceptibility and antidepressant response

Publication Details
Publication Date
2007-01-12
Journal
Publisher
ISSN
Access Type
Author Information
Authors
Tadafumi Kato
Explore further
Open the scid.ai AI chat with a ready-made request: it will find papers on a similar topic and help build a literature review.
Find similar papers in the chat
Make a presentation
100%